Quantum Biopharma (QNTM) Competitors $13.90 -0.54 (-3.74%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$14.12 +0.23 (+1.62%) As of 10/24/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QNTM vs. ZURA, MDWD, PYXS, TARA, GNFT, RANI, EPRX, CHRS, SAVA, and ELDNShould you be buying Quantum Biopharma stock or one of its competitors? The main competitors of Quantum Biopharma include Zura Bio (ZURA), MediWound (MDWD), Pyxis Oncology (PYXS), Protara Therapeutics (TARA), GENFIT (GNFT), Rani Therapeutics (RANI), Eupraxia Pharmaceuticals (EPRX), Coherus Oncology (CHRS), Cassava Sciences (SAVA), and Eledon Pharmaceuticals (ELDN). These companies are all part of the "pharmaceutical products" industry. Quantum Biopharma vs. Its Competitors Zura Bio MediWound Pyxis Oncology Protara Therapeutics GENFIT Rani Therapeutics Eupraxia Pharmaceuticals Coherus Oncology Cassava Sciences Eledon Pharmaceuticals Zura Bio (NASDAQ:ZURA) and Quantum Biopharma (NASDAQ:QNTM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment. Does the media favor ZURA or QNTM? In the previous week, Quantum Biopharma had 2 more articles in the media than Zura Bio. MarketBeat recorded 4 mentions for Quantum Biopharma and 2 mentions for Zura Bio. Zura Bio's average media sentiment score of 1.36 beat Quantum Biopharma's score of 0.50 indicating that Zura Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zura Bio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quantum Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, ZURA or QNTM? Zura Bio is trading at a lower price-to-earnings ratio than Quantum Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZura BioN/AN/A-$45.39M-$0.70-5.27Quantum BiopharmaN/AN/A-$14.20M-$14.02-0.99 Is ZURA or QNTM more profitable? Zura Bio's return on equity of -49.11% beat Quantum Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Zura BioN/A -49.11% -40.06% Quantum Biopharma N/A -270.22%-131.87% Which has more volatility & risk, ZURA or QNTM? Zura Bio has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Quantum Biopharma has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Do analysts prefer ZURA or QNTM? Zura Bio currently has a consensus target price of $11.60, indicating a potential upside of 214.36%. Given Zura Bio's stronger consensus rating and higher possible upside, equities analysts clearly believe Zura Bio is more favorable than Quantum Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zura Bio 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75Quantum Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals & insiders have more ownership in ZURA or QNTM? 61.1% of Zura Bio shares are held by institutional investors. Comparatively, 1.2% of Quantum Biopharma shares are held by institutional investors. 14.2% of Zura Bio shares are held by insiders. Comparatively, 8.5% of Quantum Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryZura Bio beats Quantum Biopharma on 10 of the 14 factors compared between the two stocks. Get Quantum Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for QNTM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QNTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNTM vs. The Competition Export to ExcelMetricQuantum BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$53.04M$3.46B$6.21B$10.81BDividend YieldN/A2.28%5.72%4.80%P/E Ratio-0.9928.5131.6030.98Price / SalesN/A497.40595.06133.64Price / CashN/A46.9537.2561.86Price / Book3.0610.4012.056.61Net Income-$14.20M-$52.83M$3.34B$277.10M7 Day Performance-1.84%2.10%1.94%2.57%1 Month Performance-14.83%10.17%6.88%3.20%1 Year Performance145.41%16.57%56.06%33.22% Quantum Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNTMQuantum Biopharma0.4823 of 5 stars$13.90-3.7%N/A+145.6%$53.04MN/A-0.99N/AAnalyst ForecastGap UpZURAZura Bio3.0024 of 5 stars$3.36-0.4%$11.60+245.8%-22.2%$218.14MN/A-4.793MDWDMediWound1.9916 of 5 stars$19.50-1.0%$32.25+65.4%+5.5%$216.14M$19.86M-7.3880Analyst ForecastPYXSPyxis Oncology2.8855 of 5 stars$3.48-2.8%$7.75+122.7%-5.5%$215.82M$2.82M-2.1760Analyst ForecastTARAProtara Therapeutics1.8472 of 5 stars$5.48-1.4%$19.60+257.7%+125.7%$211.42MN/A-3.3830News CoverageAnalyst ForecastGNFTGENFIT2.1393 of 5 stars$4.16+1.8%$7.00+68.5%-22.1%$207.75M$76.77M0.00120RANIRani Therapeutics3.2381 of 5 stars$2.88+28.0%$8.50+195.0%-22.2%$206.98M$1.20M-3.16110News CoverageAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading VolumeEPRXEupraxia Pharmaceuticals2.995 of 5 stars$5.70-3.1%$11.00+93.0%+112.0%$204.97MN/A-6.7129Analyst ForecastShort Interest ↑CHRSCoherus Oncology4.1885 of 5 stars$1.75-2.5%$4.51+158.6%+110.5%$202.82M$272.21M1.13330News CoverageAnalyst ForecastSAVACassava Sciences2.4 of 5 stars$4.09-7.4%$2.00-51.0%-85.8%$198.31MN/A-1.6130Options VolumeELDNEledon Pharmaceuticals2.1979 of 5 stars$3.31-5.4%$10.00+202.0%+2.7%$198.26MN/A-2.8310Analyst Forecast Related Companies and Tools Related Companies Zura Bio Alternatives MediWound Alternatives Pyxis Oncology Alternatives Protara Therapeutics Alternatives GENFIT Alternatives Rani Therapeutics Alternatives Eupraxia Pharmaceuticals Alternatives Coherus Oncology Alternatives Cassava Sciences Alternatives Eledon Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QNTM) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quantum Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quantum Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
